Home
Mail
News
Finance
Sports
Entertainment
Search
Mobile
More...
Yahoo Finance
Search
Skip to Navigation
Skip to Main Content
Skip to Related Content
Sign in
Mail
Sign in
to view your mail
Watchlists
My Portfolio
Markets
News
Videos
Yahoo Finance Plus
Screeners
Personal Finance
Crypto
Sectors
Contact Us
Advertisement
U.S. markets open in 21 minutes
S&P Futures
5,198.75
-16.00
(-0.31%)
Dow Futures
39,189.00
-34.00
(-0.09%)
Nasdaq Futures
18,134.25
-97.25
(-0.53%)
Russell 2000 Futures
2,037.00
-12.80
(-0.62%)
Crude Oil
82.62
-0.10
(-0.12%)
Gold
2,160.90
-3.40
(-0.16%)
Ayala Pharmaceuticals, Inc. (ADXS)
Other OTC - Other OTC Delayed Price. Currency in USD
Follow
Visitors trend
2W
10W
9M
0.5974
-0.0226
(-3.65%)
At close: 11:27AM EDT
Summary
Company Insights
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Advertisement
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Subscribe to Yahoo Finance Plus Essential to download historical data
Download
Income Statement
Expand All
All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Learn more
Breakdown
ttm
12/31/2021
12/31/2020
Total Revenue
1,733
3,506
3,708
Cost of Revenue
1,643
3,506
3,708
Gross Profit
90
0
0
Operating Expense
37,632
39,218
29,777
Operating Income
-37,542
-39,218
-29,777
Net Non Operating Interest Income Expense
-224
-260
56
Pretax Income
-37,766
-39,478
-29,721
Tax Provision
708
776
425
Net Income Common Stockholders
-38,474
-40,254
-30,146
Diluted NI Available to Com Stockholders
-38,474
-40,254
-30,146
Basic EPS
-2.51
-2.80
-3.06
Diluted EPS
-2.51
-2.80
-3.06
Basic Average Shares
15,325
14,399
9,861
Diluted Average Shares
15,325
14,399
9,861
Total Operating Income as Reported
-37,542
-39,218
-29,777
Total Expenses
39,275
42,724
33,485
Net Income from Continuing & Discontinued Operation
-38,474
-40,254
-30,146
Normalized Income
-38,474
-40,254
-30,146
Interest Income
-
-
56
Interest Expense
-
260
-
Net Interest Income
-224
-260
56
EBIT
-37,542
-39,218
-29,777
EBITDA
-37,393
-39,050
-29,595
Reconciled Cost of Revenue
1,643
3,506
3,708
Reconciled Depreciation
149
168
182
Net Income from Continuing Operation Net Minority Interest
-38,474
-40,254
-30,146
Normalized EBITDA
-37,393
-39,050
-29,595
Tax Rate for Calcs
0
0
0
Tax Effect of Unusual Items
0
0
0
Yahoo Finance Plus Essential access required.
Learn more
Advertisement
Advertisement
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Your Privacy Choices
About Our Ads
Sitemap
© 2024 Yahoo. All rights reserved.